Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II

Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II

Global polio eradication requires both safe and effective vaccines, and safe production processes. Sabin oral poliomyelitis vaccine (OPV) strains can evolve to virulent viruses and result in poliomyelitis outbreaks, and conventional inactivated poliomyelitis vaccine (Salk-IPV) production includes ac...

Full description

Bibliographic Details
Main Authors: Anastasia Piniaeva, Georgy Ignatyev, Liubov Kozlovskaya, Yury Ivin, Anastasia Kovpak, Alexander Ivanov, Anna Shishova, Liliia Antonova, Yusuf Khapchaev, Irina Feldblium, Olga Ivanova, Aleksandra Siniugina, Aydar Ishmukhametov
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
Sabin strain
inactivated vaccine
IPV
poliovirus
clinical trial
Online Access:https://www.mdpi.com/2076-393X/9/6/565

Internet

https://www.mdpi.com/2076-393X/9/6/565

Similar Items